Skip to main content
OpenTrials
Completed

NCT Number: NCT03749200

Motivational Approach to Treat Childhood Obesity

The treatment of childhood obesity is challenging. Although dietary and physical activity recommendations are widely known, the willingness to change lifestyles within the family is not easy to be achieved. Motivational interviewing has been shown as a possibly effective method to increase adherence to dietary recommendations in the obese adult.

There is scarce evidence showing whether implementing a motivational interview in obese children could be effective.

The aim of this clinical trial is assessing the effect of a motivational interview, coordinated between the clinical and primary care services on 8 to 14 years old obese children.

Completed

Looking for future studies?

Notify Me

Key information

Age range

8 year–15 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Faculty of Medicine, C/ Sant Llorenç 21, Reus, Tarragona, Spain

Loading trial locations.

About this study

In a recent study, the investigators have demonstrated that the motivational therapy approach to treat childhood obesity is highly effective at clinical and metabolic levels. This efficacy has been proved in a clinical outpatient setting. However, a standardized collaborative approach between the clinic and the primary care services would allow a faster and easier approach to childhood obesity treatment. Furthermore, this motivational and educational intervention would benefit from the current technologic facilities, the long term effect of the education at group level, in terms of food shopping plan, healthy, fast and easy cooking methods.

The aim of this clinical trial is to test the efficacy of a multicomponent motivational intervention for the treatment of childhood obesity, coordinated between primary care and hospital specialized services, integrating motivational individual interviews, educational groups and eHealth tools (wearable), compared to the usual intervention performed in paediatrics.

The design will be a clustered randomized control trial, with an intervention group that will receive a multicomponent motivational and educational plan which will be compared to a control group receiving the usual recommendations performed in primary care centres (n=167 per group). The treatment of both study groups will last 12 months and will be performed at the primary care centres. In parallel, the study team will validate the methodology used to assess body composition in obese children as well as the changes produced by the intervention.

Children assigned to the control group receive advices as recommended by the Clinical Practice Guidelines (17). At visits, the family receive explanations about carrying out a balanced diet, divided into 5 meals, in order to provide a moderate energy intake reduction. An increase in physical activity, both in terms of leisure activity, as sports regular practise are recommended. Monthly visits are organized in which weight and height are measured, and compliance with recommendations are actually taking place.

Children assigned to the intervention group receive similar recommendations to those in the control group but under a motivational interview schema. This means that each visit, objectives from the last visit are fulfiled, the therapists try to make the family recongnizing the changes to be done by themselves, rather than imposing by demonstrating ambivalences, and objectives for the next visit are agreed. Furthermore, three workshops as group therapy are organized with the following topics: 1. Increasing physical actty sing an eHEalth monitor, 2. Food choices and dietary balance, and 3. Cooking methods.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age range between 8 and <14 years at enrolment (so that, children would end the treatment at maximum age of 15 years
  • BMI > 97th percentile of Hernandez references from 1988 (Hernández et al., 1988) as indicated by the Guidelines for Clinical Practice of the Spanish Health System (Grupo de trabajo de la Guía de Práctica Clínica sobre la Prevención y el Tratamiento de la Obesidad Infantojuvenil. Ministerio de Ciencia e Innovación [Spanish Ministry of Sciencee and Innovation], 2009) for the diagnose of the childhood obesity.

Exclusion criteria

  • Children with eating disorders
  • Families not available to attend to scheduled visits
  • Simultaneous participation in another clinical trial
  • Presence of endocrine disorders (GH disorder, hypothyroidism, Cushing's disease, early puberty or other)
  • Lack of command of local languages

Treatment and study plan

Obemat2.0 therapy

Other

Regular practise in primary care

Other

Primary outcomes

  1. Body Mass Index z-score

    Time frame: 12 (+3) months

    Changes in BMI z-score between the baseline visit and the final assessment

Secondary outcomes

  1. Abdominal obesity (waist circumference)

    Time frame: 12 (+3) months

    Changes in waist circumference (cm) between the baseline visit and the final assessment

  2. Abdominal obesity (waist to height)

    Time frame: 12 (+3) months

    Changes in waist-to-height circumference (ratio) between the baseline visit and the final assessment

  3. Body composition: fat mass (kg)

    Time frame: 12 (+3) months

    Changes in fat mass (kg) between the baseline visit and the final assessment

  4. Body composition: lean mass (kg)

    Time frame: 12 (+3) months

    Changes in lean mass (kg) between the baseline visit and the final assessment

  5. Body composition: fat mass index (kg/m2)

    Time frame: 12 (+3) months

    Changes in fat mass index between the baseline visit and the final assessment

  6. Body composition: lean mass index (kg/m2)

    Time frame: 12 (+3) months

    Changes in lean mass index between the baseline visit and the final assessment

  7. HOMA-IR

    Time frame: 12 (+3) months

    Changes in insulin resistance between the baseline visit and the final assessment

  8. Blood Pressure

    Time frame: 12 (+3) months

    Changes in systolic and diastoli blood pressure (s-score) between the baseline visit and the final assessment

  9. Tryglycerides

    Time frame: 12 (+3) months

    Changes in tryglycerides (mg/dl) between the baseline visit and the final assessment

Sponsors and collaborators

Lead sponsor

Institut Investigacio Sanitaria Pere Virgili

Other

Collaborators

  • Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
  • Hospital Universitari Joan XXIII de Tarragona.
  • Hospital Universitari Sant Joan de Reus
  • Institut Català de la Salut
  • Instituto de Salud Carlos III
  • University Rovira i Virgili

Registry information

Official study title

Clinical and Metabolic Efficacy of the Motivational Approach, Coordinated Between Primary Care and the Clinical Health Services for Childhood Obesity Treatment: Randomized Clinical Trial

Acronym: OBEMAT20

Important dates

Study start
2016
Primary completion
2020
Study completion
2021
First posted
Nov 21, 2018
Registry last updated
Jun 3, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.